Larvol Delta - Diakonos-Oncology-Awarded-FDA-Fast-Track-Designation-for-Innovative-Dendritic-Cell-Vaccine-for-Glioblastoma

DOC1021 - Diakonos Research

https://www.businesswire.com/news/home/20231017772179/en/Diakonos-Oncology-Awarded-FDA-Fast-Track-Designation-for-Innovative-Dendritic-Cell-Vaccine-for-Glioblastoma

Oct 17, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next